Abstract:Transition metal complexes with substituted high affinity mixed ligands as potential anticancer agents can overcome the drawbacks of platinum-based drugs that are currently being marketed. Here, a new watersoluble asymmetric binuclear iminodiacetato-zinc(II) complex [Zn-2(ida)(phen)(3)(NO3)]center dot NO3 center dot 5H(2)O (1) with a phenanthroline ligand has been synthesized and fully characterized with a wide range of analytical techniques including single crystal X-ray diffraction as well as spectroscopic techniques, such as FT-IR, UV/Vis, photoluminescence spectroscopy, and furthermore by elemental and thermogravimetric analyses. Moreover, unprecedented (H2O)(10) water clusters consisting of a quasi-planar tetramer and six dangling water molecules were observed in the void space of 3D supramolecular assemblies. The conversion behavior of (1) into two monomeric species [Zn(ida)(phen)(H2O)] (2) and [Zn(phen)(2)(H2O)(2)](2+) (3) in aqueous solution was first studied by solid-state/solution NMR, ESI-MS, and solution UV/vis spectra. Next, these zinc(II) complexes (1-3), a mixture of (2) and (3) (mole ratio 1/1), ligands (phen and ida) and zinc ions (ZnCl2 and ZnSO4) were further evaluated for the in vitro cytotoxic profile in human hepatoma cell lines (HepG(2) and SMMC-7721). We found that complex (1) effectively inhibited the proliferation of hepatocellular carcinoma cells, which is similar to a mixture of (2) and (3) in a 1 : 1 molar ratio, and IC50 values of (1) were almost about 20-50% of (2) or (3). Therefore, this binuclear complex (1) mainly acts as a cooperative inhibitor with complexes (2) and (3) toward tumor growth in solution. We further extended the preliminary research of complex (1) and found that (1) could induce cell cycle arrest at the G0/G1 phase. Additionally, overdosing on (1) exhibited low toxicity of mice (LD50 of (1) in ICR mice = 736 mg kg(-1), with 95% confidence interval 635-842 mg kg(-1)). In conclusion, complex (1) with a high antitumor activity and low toxicity provides a new strategy for the treatment of liver cancer.

Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex

Development of a Zinc(ii) 2-Pyridinecarboxaldehyde Thiosemicarbazone Complex with Remarkable Antitumor and Antiangiogenic Activities.

Synthesis of a series of novel In(III) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism

Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.

Thiosemicarbazone Cu(II) and Zn(II) Complexes As Potential Anticancer Agents: Syntheses, Crystal Structure, DNA Cleavage, Cytotoxicity and Apoptosis Induction Activity.

An Asymmetric Binuclear Zinc(Ii) Complex With Mixed Iminodiacetate And Phenanthroline Ligands: Synthesis, Characterization, Structural Conversion And Anticancer Properties

Structure and Biological Properties of Mixed-Ligand Cu(II) Schiff Base Complexes As Potential Anticancer Agents.

In Vitro and in Vivo Anticancer Activities of Bi(III) 2-Thiazolecarboxaldehyde Thiosemicarbazone Complex

Bifunctional tetrazole–carboxylate ligand based Zn(II) complexes: synthesis and their excellent potential anticancer properties

Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides

Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2-n-(2-quinolylmethylene)aminophenol.

Synthesis, Antiproliferative Activity and Mechanism of Copper(ii)-Thiosemicarbazone Complexes As Potential Anticancer and Antimicrobial Agents

A thiosemicarbazone copper(II) complex as a potential anticancer agent

Synthesis, Crystal Structure and Antiproliferative Mechanisms of 2-Acetylpyridine-thiosemicarbazones Ga(III) with a Greater Selectivity Against Tumor Cells.

Synthesis and Crystal Structure of Some Transition Metal Complexes with A Novel Bis-Schiff Base Ligand and Their Antitumor Activities

Anticancer Activity and Computational Modeling of Ternary Copper (II) Complexes with 3-Indolecarboxylic Acid and 1,10-Phenanthroline.

Syntheses, Crystal Structures and Anticancer Activities of Three Novel Transition Metal Complexes with Schiff Base Derived from 2-Acetylpyridine and L-Tryptophan

Anticancer activity and biophysical reactivity of copper complexes of 2-(benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides

Design, Synthesis, Antimicrobial, and Anticancer Activities of Acridine Thiosemicarbazides Derivatives

Novel thiosemicarbazone complexes as anticancer agents: Synthesis, characterization, cytotoxicity, docking, and density functional theory studies

Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.